Literature DB >> 29442467

Intestinal epithelial barrier: The target for pathogenic Escherichia coli.

Barbara Pawłowska1, Beata M Sobieszczańska1.   

Abstract

Diarrheagenic Escherichia coli strains are included in 9 pathotypes (pathovars) that present different virulence factors responsible for the patomechanism of infections they cause. As all other intestinal pathogens, E. coli exerts a significant effect on intestinal epithelium. To initiate the infection, these microorganisms have evolved countless strategies to subvert the epithelial barrier and efficiently colonize the intestinal epithelium. The barrier function of the intestinal epithelium is achieved by the presence of a tight junction protein network surrounding individual cells around their circumference that links neighboring cells and seals the intracellular space. Pathogenic E. coli strains may impair intestinal epithelial barrier in 3 different pathways: (i) through a direct effect of their virulence factors on tight junctions proteins, (ii) by disrupting host cell actin cytoskeleton that indirectly damages epithelial barrier, and (iii) via stimulation of the secretion of proinflammatory cytokines that directly disrupt epithelial tight junctions or trigger neutrophils migration through intestinal epithelium, thus disrupting the intestinal barrier. Most pathogenic E. coli generates all these 3 pathways concomitantly upon interaction with intestinal epithelium.

Entities:  

Keywords:  Escherichia coli; intestinal barrier; tight junctions

Mesh:

Substances:

Year:  2017        PMID: 29442467     DOI: 10.17219/acem/64883

Source DB:  PubMed          Journal:  Adv Clin Exp Med        ISSN: 1899-5276            Impact factor:   1.727


  14 in total

1.  Infection with a human-derived enteroinvasive Escherichia coli strain altered intestinal barrier function in guinea pigs.

Authors:  Jian-Jun Liu; Juan-Juan Qiu; Xiu Shan; Xue-Qi Shang; Fu-Bo Sun; Ju-Ying Jiao; Ayaz Ahmed; Yi Xin; Dong Shang
Journal:  Int Microbiol       Date:  2022-06-20       Impact factor: 3.097

2.  l-Ergothioneine Exhibits Protective Effects against Dextran Sulfate Sodium-Induced Colitis in Mice.

Authors:  Yanju Gao; Bo Zhou; Han Zhang; Lin Chen; Xiaohong Wang; Hongbing Chen; Lin Zhou
Journal:  ACS Omega       Date:  2022-06-14

3.  One-year supplementation with Lactobacillus reuteri ATCC PTA 6475 counteracts a degradation of gut microbiota in older women with low bone mineral density.

Authors:  Peishun Li; Boyang Ji; Hao Luo; Daniel Sundh; Mattias Lorentzon; Jens Nielsen
Journal:  NPJ Biofilms Microbiomes       Date:  2022-10-19       Impact factor: 8.462

4.  Assessment of Antimicrobial Effects on Broiler Gut Barrier Through Histopathology and Immunohistochemistry of Tight-Junction Proteins.

Authors:  Matteo Cuccato; Frine Eleonora Scaglione; Cinzia Centelleghe; Sara Divari; Bartolomeo Biolatti; Paola Pregel; Francesca Tiziana Cannizzo
Journal:  Front Vet Sci       Date:  2022-03-29

Review 5.  Clever Cooperation: Interactions Between EspF and Host Proteins.

Authors:  Ying Hua; Kaina Yan; Chengsong Wan
Journal:  Front Microbiol       Date:  2018-11-22       Impact factor: 5.640

Review 6.  RNA-Sequencing Analyses of Small Bacterial RNAs and their Emergence as Virulence Factors in Host-Pathogen Interactions.

Authors:  Idrissa Diallo; Patrick Provost
Journal:  Int J Mol Sci       Date:  2020-02-27       Impact factor: 5.923

Review 7.  Escherichia coli as a Multifaceted Pathogenic and Versatile Bacterium.

Authors:  Vânia Santos Braz; Karine Melchior; Cristiano Gallina Moreira
Journal:  Front Cell Infect Microbiol       Date:  2020-12-21       Impact factor: 5.293

Review 8.  What Is Our Understanding of the Influence of Gut Microbiota on the Pathophysiology of Parkinson's Disease?

Authors:  Amaryllis E Hill; Richard Wade-Martins; Philip W J Burnet
Journal:  Front Neurosci       Date:  2021-08-26       Impact factor: 4.677

Review 9.  Gut Microbiota: The Potential Key Target of TCM's Therapeutic Effect of Treating Different Diseases Using the Same Method-UC and T2DM as Examples.

Authors:  Boxun Zhang; Ke Liu; Haoyu Yang; Zishan Jin; Qiyou Ding; Linhua Zhao
Journal:  Front Cell Infect Microbiol       Date:  2022-03-30       Impact factor: 5.293

10.  The protective effects of HIF-1α activation on sepsis induced intestinal mucosal barrier injury in rats model of sepsis.

Authors:  Xiuzhen Lei; Wenbin Teng; Ying Fan; Yeke Zhu; Liuxu Yao; Yuhong Li; Shengmei Zhu
Journal:  PLoS One       Date:  2022-05-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.